Page 137 - 《中国药房》2025年3期
P. 137

分、多靶点、多途径协同抗肝癌的作用机制,并加速成品                          [14]  ZHANG R Z,ZHONG L,SUN K W,et al. A study on cur‐
          研发,以期在临床中广泛应用。                                          cumol  influencing  proliferation  and  apoptosis  of  hepato‐
          参考文献                                                    cellular  carcinoma  cells  through  DJ-1/PTEN/PI3K/Akt
          [ 1 ]  MATTIUZZI  C,LIPPI  G.  Current  cancer  epidemiology  pathway[J]. Biomed Res Int,2022,2022(1):9912776.
              [J]. J Epidemiol Glob Health,2019,9(4):217-222.  [15]  HE X F,MA W J,HU J,et al. Diverse structures and anti‐
          [ 2 ]  LLOVET  J  M,KELLEY  R  K,VILLANUEVA A,et  al.   hepatoma effect of sesquiterpenoid dimers from Artemisia
              Hepatocellular  carcinoma[J].  Nat  Rev  Dis  Primers,  eriopoda by Akt/STAT signaling pathway[J]. Signal Trans‐
              2021,7(1):6.                                        duct Target Ther,2023,8(1):64.
          [ 3 ]  YANG  C,ZHANG  H  L,ZHANG  L  M,et  al.  Evolving   [16]  LI X D,CHEN Q C,LIU J,et al. Orphan nuclear receptor
              therapeutic landscape of advanced hepatocellular carcinoma  Nur77  mediates  the  lethal  endoplasmic  reticulum  stress
              [J]. Nat Rev Gastroenterol Hepatol,2023,20(4):203-222.  and therapeutic efficacy of Cryptomeridiol in hepatocellular
          [ 4 ]  LAIDLAW T  M,CAHILL  K  N.  Current  knowledge  and   carcinoma[J]. Cells,2022,11(23):3870.
              management  of  hypersensitivity  to  aspirin  and  NSAIDs  [17]  杨立苑,程菊,陈建军,等. 倍半萜类化合物生物学活性
              [J]. J Allergy Clin Immunol Pract,2017,5(3):537-545.  研究进展[J]. 中国实验方剂学杂志,2024,30(5):289-298.
          [ 5 ]  REN W D,WANG W H,GUO Y L. Analysis of adverse    YANG L Y,CHENG J,CHEN J J,et al. Biological activi‐
              reactions  of  aspirin  in  prophylaxis  medication  based  on   ties  of  sesquiterpenoids:a  review[J].  Chin  J  Exp  Tradit
              FAERS  database[J].  Comput  Math  Methods  Med,2022,  Med Formulae,2024,30(5):289-298.
              2022:7882277.                                  [18]  AHMAD WANI N,ZHANG B,TENG K Y,et al. Repro‐
          [ 6 ]  ANWANWAN  D,SINGH  S  K,SINGH  S,et  al.  Chal‐  graming of glucose metabolism by zerumbone suppresses
              lenges  in  liver  cancer  and  possible  treatment  approaches  hepatocarcinogenesis[J].  Mol  Cancer  Res,2018,16(2):
              [J]. Biochim Biophys Acta Rev Cancer,2020,1873(1):  256-268.
              188314.                                        [19]  SAMAD N A,ABDUL A B,RAHMAN H S,et al. Zerum‐
          [ 7 ]  HUANG  M,LU  J  J,HUANG  M  Q,et  al.  Terpenoids:  bone suppresses angiogenesis in HepG2 cells through inhi‐
              natural products for cancer therapy[J]. Expert Opin Investig   bition of matrix metalloproteinase-9,vascular endothelial
              Drugs,2012,21(12):1801-1818.                        growth  factor,and  vascular  endothelial  growth  factor
          [ 8 ]  郭杰,王家平,彭博,等. 天然愈创木烷型倍半萜类成分                       receptor expressions[J]. Pharmacogn Mag,2018,13(4):
              及其生物活性研究进展[J]. 中国中药杂志,2023,48                       S731-S736.
              (21):5727-5749.                                [20]  NA-BANGCHANG  K,PLENGSURIYAKARN  T,
              GUO J,WANG J P,PENG B,et al. Research progress on   KARBWANG  J.  Research  and  development  of  Atracty‐
              natural guaiane-type sesquiterpenoids and their biological   lodes  lancea (Thunb)  DC.  as  a  promising  candidate  for
              activities[J].  China  J  Chin  Mater  Med,2023,48(21):  cholangiocarcinoma  chemotherapeutics[J].  Evid  Based
              5727-5749.                                          Complement Alternat Med,2017,2017:592934.
          [ 9 ]  WANG  J,LI  X  M,BAI  Z,et  al.  Curcumol  induces  cell   [21]  CHENG Y,CHEN T Y,YANG X L,et al. Atractylon in‐
              cycle  arrest  in  colon  cancer  cells  via  reactive  oxygen      duces apoptosis and suppresses metastasis in hepatic cancer
              species  and  Akt/GSK3β/cyclin  D1  pathway[J].  J  Ethno‐  cells  and  inhibits  growth  in  vivo[J].  Cancer  Manag  Res,
              pharmacol,2018,210:1-9.                             2019,11:5883-5894.
          [10]  MARINI M B,DE FREITAS W R,DA SILVA MACHADO   [22]  CHENG Y,PING J,CHEN J J,et al. Molecular mecha‐
              F  L,et  al.  Cytotoxic  activity  of  halogenated  sesquiter‐  nism of atractylon in the invasion and migration of hepatic
              penes  from  Laurencia  dendroidea[J].  Phytother  Res,  cancer cells based on high-throughput sequencing[J]. Mol
              2018,32(6):1119-1125.                               Med Rep,2022,25(4):112.
          [11]  KO W,PARK J S,KIM K W,et al. Nardosinone-type ses‐  [23]  CHEIKH I A,EI-BABA C,YOUSSEF A,et al. Lessons
              quiterpenes from the hexane fraction of Nardostachys jata‐  learned from the discovery and development of the sesquiter-
              mansi attenuate NF-κB and MAPK signaling pathways in   pene lactones in cancer therapy and prevention[J]. Expert
              lipopolysaccharide-stimulated BV2 microglial cells[J]. In‐  Opin Drug Discov,2022,17(12):1377-1405.
              flammation,2018,41(4):1215-1228.               [24]  SU L H,ZHANG X T,MA Y B,et al. New guaiane-type
          [12]  SATHIPATI S Y,HO S Y. Novel miRNA signature for pre‐  sesquiterpenoid  dimers  from  Artemisia  atrovirens  and
              dicting the stage of hepatocellular carcinoma[J]. Sci Rep,  their antihepatoma activity[J]. Acta Pharm Sin B,2021,11
              2020,10(1):14452.                                  (6):1648-1666.
          [13]  LI D D,ZHANG J W,LI J M. Role of miRNA sponges in   [25]  WU Z C,HUI X G,HUO L,et al. Antiproliferative effects
              hepatocellular carcinoma[J]. Clin Chim Acta,2020,500:  of isoalantolactone in human liver cancer cells are media-
              10-19.                                              ted  through  caspase-dependent  apoptosis,ROS  genera‐


          中国药房  2025年第36卷第3期                                                 China Pharmacy  2025 Vol. 36  No. 3    · 383 ·
   132   133   134   135   136   137   138   139   140